AMO's Tecnis foldable acrylic IOL:
This article was originally published in Clinica
Broadening its portfolio of acrylic intraocular lenses (IOLs), Advanced Medical Optics (AMO) has received US approval to sell its Tecnis IOL for cataract patients. The foldable device is scheduled for release in the US and Europe in September 2005. Santa Ana, California-based AMO says it is the only company to market IOLs with a claim approved by the FDA for improved functional vision and reduced spherical aberration.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.